- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02709590
Diclofenac Potassium With Lidocaine Cream in Reducing Pain During HSG (DP-L)
April 25, 2017 updated by: Ahmed Mohamed Abbas, Assiut University
Randomized Clinical Trial of Oral Diclofenac Potassium With Cervical Lidocaine Cream in Reducing Pain During HSG
The aim of our study is to determine the efficacy of oral diclofenac potassium combined with lidocaine cream on the pain scores during HSG.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
140
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cairo
-
Assiut, Cairo, Egypt, 002
- Ahmed Abbas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 42 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- any patient came for HSG
Exclusion Criteria:
- any patient has contraindication to HSG
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A
oral diclofenac potassium plus lidocaine anesthetic cream placed into their cervix immediately before HSG
|
patients will have of oral diclofenac potassium 60 minutes before the procedure plus lidocaine anesthetic cream placed into their cervix immediately before HSG
Other Names:
|
|
Placebo Comparator: Group B
oral placebo tablets plus placebo cream placed into their cervix immediately before HSG
|
patients will have of oral placebo tablet 60 minutes before the procedure plus placebo cream placed into their cervix immediately before HSG
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean pain score during hysterosalpigography by visual analog scale
Time Frame: intraoperative
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean pain score after hysterosalpigography
Time Frame: 30 minutes
|
30 minutes
|
|
side effects of medication
Time Frame: 30 minutes
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2016
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
July 1, 2016
Study Registration Dates
First Submitted
March 11, 2016
First Submitted That Met QC Criteria
March 11, 2016
First Posted (Estimate)
March 16, 2016
Study Record Updates
Last Update Posted (Actual)
April 26, 2017
Last Update Submitted That Met QC Criteria
April 25, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anesthetics
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
- Diclofenac
Other Study ID Numbers
- HS3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain Relief With HSG
-
Assiut UniversityCompleted
-
Ain Shams UniversityCompleted
-
Aalborg UniversityCompleted
-
Assiut UniversityCompleted
-
Assiut UniversityCompleted
-
Wake Forest University Health SciencesCompleted
-
IRCCS Burlo GarofoloCompleted
-
Western Galilee Hospital-NahariyaWithdrawn
Clinical Trials on diclofenac potassium + lidocaine
-
Aswan University HospitalCompletedInfertility, FemaleEgypt
-
Novartis PharmaceuticalsCompleted
-
Cairo UniversityUnknown
-
Humanis Saglık Anonim SirketiCompletedBioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated TabletAnalgesic | Non-steroidal Anti-inflammatory (NSAID) | AntipyreticJordan
-
Danish Headache CenterTerminatedMigraine Without Aura | Migraine With AuraDenmark
-
CMH Multan Institute of Medical SciencesCompletedPostoperative Pain | Cesarean Section Pain | Diclofenac | SuppositoryPakistan
-
DepomedCompleted
-
Javelin PharmaceuticalsCompleted
-
Bayero University Kano, NigeriaUnknownFemale Infertility of Tubal OriginNigeria